A dietary supplement comprising beta-glucan and casein hydrolsate for improving health and growth performance in a mammal
AssigneeUniversity College Dublin, National University of Ireland, Dublin
InventorsTorres Sweeney, John O'Doherty
Life of this patent
Estimating the term…
Abstract
A non-therapeutic method of improving growth performance of a weaning mammal comprises a step of administering to the weaning mammal or a maternal mammal an effective amount of beta-glucan and casein hydrolysate, wherein the weight ratio of beta-glucan to casein hydrolysate is 1:2 to 2:1. A dietary supplement suitable for oral administration to a mammal comprising beta-glucan and casein hydrolysate is also provided, wherein the weight ratio of beta-glucan to casein hydrolysate is 1:2 to 2:1.
Claims32
A composition comprising yeast-derived beta glucan and an enzymatically-derived casein hydrolysate, wherein the weight ratio of beta-glucan to casein hydrolysate is 1:2 to 2:1.
A composition according to any preceding claim in which the composition comprises 40 to 60% beta-glucan (w/w) and 40 to 60% casein hydrolysate (w/w).
A composition consisting essentially of yeast-derived beta glucan and an enzymatically-derived casein hydrolysate, wherein the weight ratio of beta-glucan to casein hydrolysate is 1:2 to 2:1.
A method of improving growth performance in a weaning mammal, comprising a step of administering to the weaning mammal or maternal mammal a combination of yeast-derived beta glucan and enzymatically-derived casein hydrolysate, wherein the weight ratio of beta-glucan to casein hydrolysate administered to the mammal is 1:2 to 2:1.
A combination of yeast-derived beta-glucan and enzymatically-derived casein hydrolysate, for use in a method of improving gut health in a mammal, in which the combination of yeast-derived beta-glucan and enzymatically-derived casein hydrolysate is administered to the weaning mammal or maternal mother.
A combination of yeast-derived beta glucan and enzymatically-derived casein hydrolysate, for use in a method of preventing a gastrointestinal inflammatory condition in a mammal, in which the combination of yeast-derived beta glucan and enzymatically-derived casein hydrolysate is administered to the weaning mammal or maternal mother.
An animal feed suitable for feeding to weaning mammals and comprising protein, carbohydrate, vitamins, minerals, lipid, 0.02-0.03% enzymatic-derived casein hydrolysate and 0.01-0.03% yeast-derived beta-glucan (w/w).
A food product for a pregnant or lactating human comprising comprising 0.1 to 10 g yeast-derived beta glucan and an enzymatically-derived casein hydrolysate, wherein the weight ratio of beta-glucan to casein hydrolysate is 1:2 to 2:1.
Dependencies are inferred from the claim text.